Photodynamic Therapy of Intestinal Tumors with Mono-L-aspartyl Chlorin e6 (NPe6): A Basic Study

Anticancer Research

Volumn 23, Issue 6 C, 2003, Pages 4897-4900

  Kikuchi, Tatsuya ^a   Asakura, Tohru ^a   Aihara, Hiroyuki ^a   Shiraki, Manabu ^a   Takagi, Sho ^a   Kinouchi, Yoshitaka ^a   Aizawa, Katsuo ^b   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Mono L aspartyl chlorin e6; Photodynamic diagnosis; Photodynamic therapy

Indexed keywords

PHOTOSENSITIZING AGENT; TALAPORFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIODE LASER; DRUG ACCUMULATION; DRUG TUMOR LEVEL; EXCISION; FLUORESCENCE; FROZEN SECTION; HISTOPATHOLOGY; INTESTINE MUCOSA; INTESTINE TUMOR; IRRADIATION; MICROSCOPY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; INTESTINAL NEOPLASMS; LASERS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 0842333183     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dougherty TJ, Gomer CJ and Henderson BW et al: Photodynamic therapy (review). J Natl Cancer Inst 90: 889-905, 1998.
2. Fingar VH: Vascular effects of photodynamic therapy. J Clin Laser Med 14: 323-328, 1996.
3. Sharman WM, Allen CM and van Lier JE: Photodynamic therapeutics: basic principles and clinical applications (review). Drug Discovery Today 4: 507-517, 1999.
4. Roberts WG, Shiau FY and Nelson JS et al: In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy. J Natl Cancer Inst 80: 330-336, 1988.
5. Moan J, Peng Q and Sorenser R et al: The biophysical foundation of photodynamic therapy (review). Endoscopy 30: 387-391, 1998.
6. Roberts WG, Smith KM and McCullough JL et al: Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photobiol 49: 431-438, 1989.
7. Aizawa K, Kadowaki O and Kawabe H et al: Effect of NPe6 or Photofrin II with subsequent exposure to light. Lasers Life Sci 3: 187-196, 1990.
8. Moser AR, Pitot HC and Dove WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324, 1990.
9. Kato H, Aizawa K and Ono J et al: Clinical measurement of tumor fluorescence using a new diagnostic system with hematoporphyrin derivative, laser photoradiation, and a spectroscope. Lasers Surg Med 4 (1): 49-58, 1984.
10. Aizawa K, Okunaka T and Ohtani T et al: Localization of mono-sapartyl chlorin e6 (NPe6) in mouse tissues. Photochem Photobiol 46: 789-93, 1987.
11. Katsumi T, Aizawa K and Kroiwa Y et al: Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-1-aspartyl chlorin e6. Photochem Photobiol 64(4): 671-75, 1996.
12. Manyak MJ, Russo A and Smith PD et al: Photodynamic therapy. J Clin Oncol 6: 380-91, 1988.
13. Spinelli P and Dal Fante M: Photodynamic therapy of solid tumors. Semin Hematol 29: 142-54, 1992.
14. Marcon NE: Photodynamic therapy and cancer of the esophagus. Semin Oncol 21: 20-3, 1994.
15. Tajiri H, Daikuzono N and Joffe SN et al: Photoradiation therapy in early gastrointestinal cancer. Gastrointest Endosc 33: 88-90, 1987.
16. Krasner N, Chatlani PT and Barr H: Photodynamic therapy of tumors in gastroenterology: a review. Lasers Med Sci 5: 233-8, 1990.
17. Ortner M, Schreiber S and Liebetruth J et al: Photodynamic therapy of stage IV cholangiocellular carcinoma. Gastroenterology 110: A472, 1996.
18. Louis-Michel Wong Keee Song, Kenneth K and Alan R Zinsmeister: Mono-L-aspartyl chlorin e6(NPe6) and hematoporphyrin derivative(HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 82: 421-27, 1998.